Advertisement

Syphilis

  • Molly Hartrich
  • Taku Taira
Chapter

Abstract

Syphilis is known as “the great imitator” of disease which makes diagnosis challenging. This designation stands for the skin manifestations of T. pallidum as well. The rashes and skin lesions of syphilis are numerous and varied, particularly when individuals are coinfected with HIV. The classic painless chancre of primary syphilis and the palmar-plantar rash of secondary syphilis are important physical exam criteria to know but are only two of the numerous cutaneous manifestations of the disease. This chapter seeks to familiarize clinicians with some other skin findings that are less well known and may be confused with other disease mimics. In addition, the diagnostic and treatment pathways are described which also depend on disease stage.

Keywords

Syphilis Primary syphilis Secondary syphilis Neurosyphilis Tertiary syphilis Spirochete HIV AIDS Chancre Rash Gumma Lues maligna Penicillin Jarisch-Herxheimer reaction 

References

  1. 1.
    Centers for Disease Control and Prevention (CDC). Primary and secondary syphilis—United States, 2003-2004. JAMA. 2006;295:1890–1.  https://doi.org/10.1001/jama.295.16.1890.CrossRefGoogle Scholar
  2. 2.
    Peterman TA, Heffelfinger JD, Swint EB, Groseclose SL. The changing epidemiology of syphilis. Sex Transm Dis. 2005;32(10 Suppl):S4–10.CrossRefPubMedGoogle Scholar
  3. 3.
    Barton J, Braxton J, Davis DW, et al. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2015. Atlanta: U.S. Department of Health and Human Services; 2016.Google Scholar
  4. 4.
    Karapetyan AF, Sokolovsky YV, Araviyskaya ER, et al. Syphilis among intravenous drug-using population: epidemiological situation in St Petersburg, Russia. Int J STD AIDS. 2016;13:618–23.  https://doi.org/10.1258/09564620260216326.CrossRefGoogle Scholar
  5. 5.
    Chen Z-Q, Zhang G-C, Gong X-D, et al. Syphilis in China: results of a national surveillance programme. Lancet. 2007;369:132–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Simms I, Fenton KA, Ashton M, et al. The re-emergence of syphilis in the United Kingdom: the new epidemic phases. Sex Transm Dis. 2005;32:220.CrossRefPubMedGoogle Scholar
  7. 7.
    Martin IE, Tsang RSW, Sutherland K, et al. Molecular characterization of syphilis in patients in Canada: azithromycin resistance and detection of Treponema pallidum DNA in whole-blood samples versus ulcerative swabs. J Clin Microbiol. 2009;47:1668–73.  https://doi.org/10.1128/JCM.02392-08.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Stamm LV. Global challenge of antibiotic-resistant Treponema pallidum. Antimicrob Agents Chemother. 2010;54:583–9.  https://doi.org/10.1128/AAC.01095-09.CrossRefPubMedGoogle Scholar
  9. 9.
    Lautenschlager S. Cutaneous manifestations of syphilis: recognition and management. Am J Clin Dermatol. 2006;7:291–304.CrossRefPubMedGoogle Scholar
  10. 10.
    Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis. 2004;4:456–66.  https://doi.org/10.1016/S1473-3099(04)01061-8.CrossRefPubMedGoogle Scholar
  11. 11.
    Lautenschlager S. Cutaneous manifestations of syphilis. Am J Clin Dermatol. 2006;7:291.CrossRefPubMedGoogle Scholar
  12. 12.
    Chapel TA, Prasad P, Chapel J, Lekas N. Extragenital syphilitic chancres. J Am Acad Dermatol. 1985;13:582–4.  https://doi.org/10.1016/S0190-9622(85)70200-9.CrossRefPubMedGoogle Scholar
  13. 13.
    Schofer H. Syphilis Klinik der Treponema-pallidum-Infektion. Der Hautarzt. 2004.Google Scholar
  14. 14.
    Haustein UF, Pfeil B, Zschiesche A. Analyse der von 1983–1991 an der Universitäts-Hautklinik Leipzig beobachteten Syphilisfälle. Der Hautarzt. 1993.Google Scholar
  15. 15.
    Alam F, Argiriadou AS, Hodgson TA, Kumar N, Porter SR. Primary syphilis remains a cause of oral ulceration. Br Dent J. 2000;189(7):352–4.PubMedGoogle Scholar
  16. 16.
    Arunkumar S, Prasad S, Loganathan B, et al. Extragenital chancre of the tongue. Int J STD AIDS. 2016;8:655–6.  https://doi.org/10.1258/0956462971918814.CrossRefGoogle Scholar
  17. 17.
    Sanchez MR. Syphilis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editors. Fitzpatricks dermatology in general medicine. 6th ed. New York: McGraw-Hill; 2003. p. 2163–88.Google Scholar
  18. 18.
    Workowski KA, Berman SM. Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2007;44(Suppl 3):S73–6.  https://doi.org/10.1086/511430.CrossRefPubMedGoogle Scholar
  19. 19.
    Singh AE, Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev. 1999;12:187–209.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Radolf JD, Tramont EC, Salazar JC. 239 – Syphilis (Treponema pallidum). In: Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier/Saunders; 2015. p. 2684–709.e5.  https://doi.org/10.1016/B978-0-323-40161-6.00239-4.CrossRefGoogle Scholar
  21. 21.
    Augenbraun M. 24 syphilis and the nonvenereal treponematoses. 2003;  https://doi.org/10.2310/7900.1234.
  22. 22.
    de Vries HJC. Skin as an indicator for sexually transmitted infections. Clin Dermatol. 2014;32:196–208.  https://doi.org/10.1016/j.clindermatol.2013.08.003.CrossRefPubMedGoogle Scholar
  23. 23.
    Centers for Disease Control and Prevention. Recommendations for public health surveillance of syphilis in the United States. Atlanta: US Department of Health and Human Services; 2003.Google Scholar
  24. 24.
    World Health Organization. Guidelines for the management of sexually transmitted infections. World Health Organization. 2003. ISBN: 9241546263.Google Scholar
  25. 25.
    Chudomirova K, Chapkanov A, Abadjieva T, Popov S. Gummatous cutaneous syphilis. Sex Transm Dis. 2009;36:239–40.  https://doi.org/10.1097/OLQ.0b013e3181917202.CrossRefPubMedGoogle Scholar
  26. 26.
    Cohen SE, Klausner JD, Engelman J, Philip S. Syphilis in the modern era: an update for physicians. Infect Dis Clin North Am. 2013;27:705–22.  https://doi.org/10.1016/j.idc.2013.08.005.CrossRefPubMedGoogle Scholar
  27. 27.
    Dourmishev LA, Dourmishev AL. Syphilis: uncommon presentations in adults. Clin Dermatol. 2005;23:555–64.  https://doi.org/10.1016/j.clindermatol.2005.01.015.CrossRefPubMedGoogle Scholar
  28. 28.
    Tait IA. Uveitis due to secondary syphilis. Sex Transm Infect. 1983;59:397.CrossRefGoogle Scholar
  29. 29.
    Sivaram M, Radcliffe KW. Acute visual loss as a presenting manifestation of syphilis. Int J STD AIDS. 2007;18(6):429–30.CrossRefPubMedGoogle Scholar
  30. 30.
    Eandi CM, Neri P, Adelman RA, Yannuzzi LA, Cunningham ET Jr, Group ISS. Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Retina. 2012;32(9):1915–41.CrossRefPubMedGoogle Scholar
  31. 31.
    Diseases AAOPCOI (2015) Red Book.Google Scholar
  32. 32.
    Shah S. Pediatric practice infectious diseases: McGraw Hill Professional; New York, NY. 2008.Google Scholar
  33. 33.
    Tight RR, Warner JF. Skeletal involvement in secondary syphilis detected by bone scanning. JAMA. 1976;235:2326.CrossRefPubMedGoogle Scholar
  34. 34.
    Campisi D, Whitcomb C. Liver disease in early syphilis. Arch Intern Med. 1979;139:365.CrossRefPubMedGoogle Scholar
  35. 35.
    Bhorade MS, Carag HB, Lee HJ, Potter EV. Nephropathy of secondary syphilis: a clinical and pathological spectrum. JAMA. 1971;216(7):1159–66.CrossRefPubMedGoogle Scholar
  36. 36.
    Winters HA, Notar-Francesco V, Bromberg K, Rawstrom SA, Vetrano J, Prego V, et al. Gastric Syphilis: Five Recent Cases and a Review of the Literature. Ann Intern Med. 1992;116:314–319.  https://doi.org/10.7326/0003-4819-116-4-314.
  37. 37.
    Watts PJ, Greenberg HL, Khachemoune A. Unusual primary syphilis: presentation of a likely case with a review of the stages of acquired syphilis, its differential diagnoses, management, and current recommendations. Int J Dermatol. 2016;55:714–28.  https://doi.org/10.1111/ijd.13206.CrossRefPubMedGoogle Scholar
  38. 38.
    Lleó MI, Escribano PC, Prieto BM. Atypical cutaneous manifestations in syphilis. Actas Dermo-Sifiliográficas (English Edition). 2016;107:275–83.  https://doi.org/10.1016/j.adengl.2016.02.002.CrossRefGoogle Scholar
  39. 39.
    Balagula Y, Mattei PL, Wisco OJ, et al. The great imitator revisited: the spectrum of atypical cutaneous manifestations of secondary syphilis. Int J Dermatol. 2014;53:1434–41.  https://doi.org/10.1111/ijd.12518.CrossRefPubMedGoogle Scholar
  40. 40.
    Baughn RE, Musher DM. Secondary syphilitic lesions. Clin Microbiol Rev. 2005;18:205–16.  https://doi.org/10.1128/CMR.18.1.205-216.2005.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Kelly JD, LeLeux TM, Citron DR, et al. Ulceronodular syphilis (lues maligna praecox) in a person newly diagnosed with HIV infection. BMJ Case Rep. 2011;2011:bcr1220103670.  https://doi.org/10.1136/bcr.12.2010.3670.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Centers for Disease Control and Prevention (CDC). Discordant results from reverse sequence syphilis screening – five laboratories, United States, 2006-2010. MMWR Morb Mortal Wkly Rep. 2011;60:133–7.Google Scholar
  43. 43.
    Nandwani R, Evans DT. Are you sure it’s syphilis? A review of false positive serology. Int J STD AIDS. 1995;6(4):241–8.  https://doi.org/10.1177/095646249500600404.CrossRefPubMedGoogle Scholar
  44. 44.
    Libois AS, De Wit SP, Poll BND, et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis. 2007;34:141–4.  https://doi.org/10.1097/01.olq.0000230481.28936.e5.CrossRefPubMedGoogle Scholar
  45. 45.
    Ciesielski CA. Sexually transmitted diseases in men who have sex with men: an epidemiologic review. Curr Infect Dis Rep. 2003;5:145.CrossRefPubMedGoogle Scholar
  46. 46.
    Su JR, Weinstock H (2011) Epidemiology of co-infection with HIV and syphilis in 34 states, United States—2009. In: Proceedings of the 2011 national HIV prevention ….Google Scholar
  47. 47.
    Centers for Disease Control and Prevention (CDC). Notes from the field: repeat syphilis infection and HIV coinfection among men who have sex with men – Baltimore, Maryland, 2010-2011. MMWR Morb Mortal Wkly Rep. 2013;62:649–50.Google Scholar
  48. 48.
    Shockman S, Buescher LS, Stone SP. Syphilis in the United States. Clin Dermatol. 2014;32:213–8.  https://doi.org/10.1016/j.clindermatol.2013.08.005.CrossRefPubMedGoogle Scholar
  49. 49.
    Zeltser R, Kurban AK. Syphilis. Clin Dermatol. 2004;22:461–8.  https://doi.org/10.1016/j.clindermatol.2004.07.009.CrossRefPubMedGoogle Scholar
  50. 50.
    Gadde J, Spence M, Wheeler B, Adkinson NF. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA. 1993;270:2456–63.  https://doi.org/10.1001/jama.1993.03510200062033.CrossRefPubMedGoogle Scholar
  51. 51.
    Alexander JM, Sheffield JS, Sanchez PJ. Efficacy of treatment for syphilis in pregnancy. Obstet Gynecol. 1999;93:5.  https://doi.org/10.1016/S0029-7844(98)00338-X.CrossRefPubMedGoogle Scholar
  52. 52.
    Nathan L, Bawdon RE, Sidawi JE, et al. Penicillin levels following the administration of benzathine penicillin G in pregnancy. Obstet Gynecol. 1993;82:338–42.PubMedGoogle Scholar
  53. 53.
    Sammet S, Draenert R. Case report of three consecutive lues maligna infections in an HIV-infected patient. Int J STD AIDS. 2017;28:523–5.  https://doi.org/10.1177/0956462416674102.CrossRefPubMedGoogle Scholar
  54. 54.
    Hook EW, Baker-Zander SA, Moskovitz BL, et al. Ceftriaxone therapy for asymptomatic neurosyphilis. Case report and Western blot analysis of serum and cerebrospinal fluid IgG response to therapy. Sex Transm Dis. 1986;13:185–8.CrossRefPubMedGoogle Scholar
  55. 55.
    Hook EW, Roddy RE, Handsfield HH. Ceftriaxone therapy for incubating and early syphilis. J Infect Dis. 1988;158:881.CrossRefPubMedGoogle Scholar
  56. 56.
    Ghanem KG, Erbelding EJ, Cheng WW, Rompalo AM. Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis. 2006;42:e45–9.  https://doi.org/10.1086/500406.CrossRefPubMedGoogle Scholar
  57. 57.
    Wong T, Singh AE, De P. Primary syphilis: serological treatment response to doxycycline/tetracycline versus benzathine penicillin. Am J Med. 2008;121:903–8.  https://doi.org/10.1016/j.amjmed.2008.04.042.CrossRefPubMedGoogle Scholar
  58. 58.
    Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med. 2005;353:1236–44.  https://doi.org/10.1056/NEJMoa044284.CrossRefPubMedGoogle Scholar
  59. 59.
    Rompalo AM, Joesoef MR, O’donnell JA, et al. Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex Transm Dis. 2001;28(3):158–65.CrossRefPubMedGoogle Scholar
  60. 60.
    Ely JW, Stone MS. The generalized rash: part II. Diagnostic approach. Am Fam Physician. 2010;15(81.), 6th ser):735–9.Google Scholar
  61. 61.
    Augenbraun MH. Diseases of the reproductive organs and sexually transmitted diseases: genital skin and mucous membrane lesions. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone; 2009. p. 475–1484.Google Scholar
  62. 62.
    Scully C. Chapter 14: Soreness and ulcers. In: Oral and maxillofacial medicine : the basis of diagnosis and treatment. 2nd ed. Edinburgh: Churchill Livingstone; 2008. p. 131–9.Google Scholar
  63. 63.
    Gevorgyan O, Owen B, Balavenkataraman A, Weinstein M. A nodular-ulcerative form of secondary syphilis in AIDS. Proc (Bayl Univ Med Cent). 2017;30(1):80–2.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Molly Hartrich
    • 1
  • Taku Taira
    • 1
  1. 1.Department of Emergency MedicineUniversity of Southern CaliforniaLos AngelesUSA

Personalised recommendations